Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01249014 · ClinicalTrials.gov registry record · NA

Temperature Study in Cesarean Section

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT01249014: Completed NA study, sponsored by Stanford University.

NCT01249014 is a NA study that has completed, run by Stanford University. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01249014, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

During surgery body temperature can decrease which can adversely affect how people recover from surgery. This is a common problem. We aim to reduce the incidence of this drop in body temperature during surgery by testing the effectiveness of warm intravenous fluids that the patients will receive as they are being infused, and of warm air blown into a blanket covering the body. The control group will not have any active warming methods. Study group 1 will have the intravenous fluid warmer in the pre- and intraoperative period. Study group 2 will have a forced-air warmer in the intra-operative period as well as the fluid warmer in the pre- and intraoperative period. We will also observe the neonates' vital signs following delivery.

Primary Outcome

measured every 15 minutes from spinal anesthetic administration

Interventions

  • OTHER Warmed fluids
  • OTHER Fluid warmer and warming blanket
  • DEVICE Belmont fluid warmer
  • DEVICE Bair hugger warming blanket

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2013-11-01
Est. Completion 2015-04-30
Phase NA
Stanford University

1,744 total trials

What the finished NCT01249014 record still lists

NCT01249014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 4 interventions - of which Warmed fluids is the first listed.

NCT01249014 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01249014 about?

NCT01249014 is a clinical study titled "Temperature Study in Cesarean Section". During surgery body temperature can decrease which can adversely affect how people recover from surgery. This is a common problem. We aim to reduce the incidence of this drop in body temperature during surgery by testing the effectiveness of warm intravenous fluids that the patients will receive as ...

What is the current status of trial NCT01249014?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2013-11-01. Estimated completion is 2015-04-30.

What interventions are being tested in trial NCT01249014?

The interventions under investigation include: Warmed fluids (OTHER), Fluid warmer and warming blanket (OTHER), Belmont fluid warmer (DEVICE), Bair hugger warming blanket (DEVICE).

Who is sponsoring clinical trial NCT01249014?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01249014's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01249014, the US trial registry maintained by the National Library of Medicine. NCT01249014 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.